Moleculin Biotech Inc (NASDAQ:MBRX) stock has reached a 52-week low, trading at $1.46, down 85% from its 52-week high of $10.35. According to InvestingPro analysis, the company maintains a favorable ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended December 31, 2024, that included the following highlights ...
Brian Lang signaled optimism about growth opportunities, particularly in the US title segment, which the company views as being at an inflection point. He announced plans to ramp up a newly secured ...
Quest Diagnostics is a leading provider of independent diagnostic testing in the United States thanks to its network of roughly 2,300 patient service centers across the country. We think its size and ...